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Expression of type I interferons (IFNs) can be
induced by DNA-damaging agents, but the mecha-
nisms and significance of this regulation are not
completely understood. We found that the transcrip-
tion factor IRF3, activated in an ATM-IKKa/b-depen-
dent manner, stimulates cell-autonomous IFN-b
expression in response to double-stranded DNA
breaks. Cells and tissues with accumulating DNA
damage produce endogenous IFN-b and stimulate
IFN signaling in vitro and in vivo. In turn, IFN acts to
amplify DNA-damage responses, activate the p53
pathway, promote senescence, and inhibit stem
cell function in response to telomere shortening.
Inactivation of the IFN pathway abrogates the devel-
opment of diverse progeric phenotypes and extends
the lifespan of Terc knockout mice. These data iden-
tify DNA-damage-response-induced IFN signaling as
a critical mechanism that links accumulating DNA
damage with senescence and premature aging.INTRODUCTION
A link between aging and DNA damage is illustrated by the accu-
mulation of DNA alterations seen in aging human and mouse
cells, accelerated aging phenotypes (progerias) observed in pa-
tients with hereditary impairments in genome maintenance, and
progressive failure of stem cell function and aging-reminiscent
tissue abnormalities observed in mouse models of persistent
DNA-damage responses (DDRs) (Garinis et al., 2008; Hastie
et al., 1990; Jiang et al., 2008; Lieber and Karanjawala, 2004; Sa-
hin andDepinho, 2010). For example, knockout of the telomerase
RNA component Terc causes progressive telomere shortening
that persistently activatesDDRand leads tonumerous abnormal-
ities in stem cell function and accelerated aging (Lee et al., 1998;Rudolph et al., 1999). At the cellular level, DDR promotes a per-
manent cell-cycle arrest (senescence)—a cellular phenotype
closely associated with aging of multicellular tissues and organs
(Campisi, 2013; Campisi and d’Adda di Fagagna, 2007).
While the links between DDR and cell senescence/aging have
been established, the molecular basis of this association is not
well understood. The contribution of secreted factors that para-
crinely propagate senescence has been extensively docu-
mented (Coppe et al., 2008a, Coppe´ et al., 2008b, 2010; Tchko-
nia et al., 2013). However, the specific role of individual cytokines
within this secretome is a subject of continuous investigation.
Here, we focused on type I interferons (IFN), anti-viral cytokines
including IFN-b and IFN-a, that are expressed in response to
activation of pathogen-associated molecular patterns under
regulation of the IRF3 and IRF7 transcription factors, respec-
tively (Katze et al., 2002). These IFNs interact with the IFNAR1/
IFNAR2 receptor complex to activate JAK-STAT signaling and
induce IFN-stimulated genes (including Irf7, Isg15, and Ifitm3),
whose products elicit anti-viral effects, and contribute to the
development of immunopathology (Bhattacharya et al., 2014;
Trinchieri, 2010).
Recent reports indeed link DDR with IFN signaling. IFN-stimu-
lated gene expression signatures are found in cells and tissues
exposed to anti-cancer drugs and ionizing radiation known to
induce DNA damage (Moschella et al., 2013; Weichselbaum
et al., 2008). These agents were shown to either activate IRF3
(Kim et al., 1999) or stimulate production of IFN (Brzostek-Racine
et al., 2011). Anti-tumorigenic effects of ionizing radiation and
chemotherapy are at least in part mediated by effects of IFN
whose production in animal tissues may rely on diverse path-
ogen recognition receptors (Burnette et al., 2011; Deng et al.,
2014; Sistigu et al., 2014). Activation of IFN signaling is described
in syndromes characterized by defects in enzymes processing/
eliminating cytoplasmic DNA (Barber, 2011b; Stetson et al.,
2008). Furthermore, genotoxic drug-induced cellular senes-
cence correlates with production of IFN and induction of IFN-
stimulated genes (Fridman and Tainsky, 2008; Mboko et al.,
2012; Novakova et al., 2010).Cell Reports 11, 785–797, May 5, 2015 ª2015 The Authors 785
However, while IFN expression is induced by radiation/anti-
cancer drugs, it is not known whether IFN is induced by the
DNA-damage signals per se or is instead induced indirectly by
accompanying induction of reactive oxygen species, which are
known to stimulate IFN expression (Eguchi et al., 2011). In addi-
tion, while many pathogen recognition receptors may be
involved in production of IFN by the debris of terminally damaged
cells, it is not clear whether IFN can be produced in the same cell
that undergoes DNA damage. Moreover, the physiologic role of
the IFN produced in response to DNA damage is not completely
understood.
Here, we report that DNA damage itself can stimulate the
production of IFN-b. Experiments using single-cell-based ana-
lyses demonstrate that low levels of IFN-b are increased
rapidly and cell-autonomously in live cells within a few hours
of the induction of double-strand breaks (DSBs). This IFN-b
production and associated cell senescence are greatly
increased in cells from progeria patients deficient in genome
maintenance genes and from knockout mice lacking the corre-
sponding genes. Neutralizing the secreted IFN-b or knocking
out/down its receptor attenuates cell senescence in vitro.
Accordingly, Ifnar1 ablation in Terc-deficient mice inhibits cell
senescence in vivo, rescues mice from stem cell decline, and
mitigates premature aging-related alterations in multiple tis-
sues and organs. These data implicate DDR-induced IFN in
cell senescence and inhibition of stem cell function associated
with accelerated aging.
RESULTS
DNA Damage Activates Cell-Autonomous Induction
of IFN-b
To avoid side effects of radiation/chemotherapeutics and focus
solely on the role of DNA damage, we used the expression of the
telomere-specific binding protein TRF1 fused to FokI nuclease
(FLAG-TRF1-FokI) that can induce DSBs in telomeric chromatin
(Tang et al., 2013). This protein (but not nuclease-deficient TRF1-
FokID450A mutant) increased expression of endogenous IFN-b
protein (Figures 1A, 1B, and S1A) and IFN-stimulated reporter
(Irf7 promoter-controlled IRF7-mCherry [Rand et al., 2012]; Fig-
ures 1C and S1B). These results together with attenuation of
IRF7-mCherry expression by anti-IFN-b neutralizing antibody
or small interfering RNA (siRNA) (Figure 1C) indicate that DSBs
inflicted by FokI activity stimulate IFN-b production to induce
IRF7 expression.
We also utilized a U2OS fibrosarcoma stable cell line that co-
expresses Lac operator-based DSB reporter (U2OSr [Shanbhag
et al., 2010]) with mCherry-LacI-FokI nuclease fused to a desta-
bilization domain and modified estradiol receptor. The resulting
chimeric nuclease, which becomes expressed in cells upon
treatment with the small molecules Shield ligand and 4-hydrox-
ytamoxifen, includes the appearance of a single localized DSB
signal (Tang et al., 2013). We observed the phospho-gH2AX
signal (within 3–6 hr of treatment) and concurrent increase of
IFN-b levels in these cells (Figures 1D, 1E, and 2A). In addition,
induction of DSB led to activating phosphorylation of STAT1
and increase in IRF7 levels (Figure 1F) further linking DDR with
the induction of IFN signaling.786 Cell Reports 11, 785–797, May 5, 2015 ª2015 The AuthorsSubsequent genetic experiments revealed attenuated IFN
signaling (Figure 1F) and IFN-b expression (Figure 2A) in
U2OSr cells treated with siRNA against IRF3. Intriguingly,
instead of the massive IRF3 nuclear import often reported in
the virus-infected cells (Lin et al., 1998), we observed limited nu-
clear entry and a focal pattern including some co-localization of
IRF3 within the vicinity of DSB (Figures 2B and 2C). A similar
pattern was seen in parental U2OS cells treated with ionizing ra-
diation (Figure S1C). These results suggest that DSBs stimulate
IRF3 focal nuclear localization and IRF3-dependent expression
of IFN-b.
An inhibitor of DNA-dependent serine/threonine protein kinase
(DNA-PK, known to stimulate IRF3 nuclear retention [Karpova
et al., 2002]) did not alter DSB-induced nuclear IRF3 foci (Figures
2C and 2D). Furthermore, these foci were not affected by RNAi
against either Rnf8/Rnf168 ubiquitin ligases (linking DSB recog-
nition with repair [Al-Hakim et al., 2010]) or ATF2 (known to regu-
late Ifnb transcription [Whitley et al., 1994]) but disappeared in
cells receiving RNAi against IRF3 itself (Figure S1D). Importantly,
treatment of cells with inhibitor of Ataxia telangiectasia mutated
kinase ATM eliminated the phospho-H2AX foci and IRF3-posi-
tive foci (Figures 2C and 2D) as well as the elevated expression
of IFN-b (Figure S1E) suggesting that ATM plays an important
role in DDR signaling toward IRF3 activation and IFN-b produc-
tion. While nuclear IRF3 foci persisted in cells transfected with
siRNA against many known IRF3 regulators (such as STING,
TBK1, RIG-I, MDA5, and IKKε [Ha¨cker and Karin, 2006; Seth
et al., 2006; Unterholzner, 2013]), the knockdown of IKKa or
IKKb IkB kinase species abrogated this IRF3 localization without
affecting phospho-H2AX foci (Figure 2E). Either inhibition of ATM
(but not DNA-PK) or knockdown of IKKa/IKKb also noticeably
decreased the induction of IFN-b in these cells (Figures 2A and
S1E), suggesting that DSB-activated ATM can signal through
IKKa/b to stimulate IRF3-driven IFN-b expression.
Notably, induction of DSB in U2OSr cells significantly
increased the steady-state Ifnb mRNA levels (Figure 3A). Trans-
fection of double-stranded DNA into mammalian cells has been
previously shown to stimulate Ifnb expression (Li et al., 2005;
Shirota et al., 2006). Intriguingly, when mouse genomic DNA
was sonicated to induce DSBs, transfected cells that received
the damaged DNA responded with a greater induction of Ifnb
mRNA than did cells transfected with intact DNA. Remarkably,
this DSB-induced Ifnb expression was sensitive to the ATM in-
hibitor (Figure 3B) further linking DDR with IFN-b production.
We then used human and mouse cells and tissues previously
shown to accumulate DSBs (Du et al., 2004). Noticeably greater
levels of Ifnb were seen in human diploid fibroblasts from pa-
tients with Werner or Hutchinson-Gilford progeria syndromes
than from normal human fibroblasts (Figure 3C). Higher Ifnb
expression was also seen in MRC-5 fibroblasts serially cultured
to late passages (shown to accumulate DNA damage [Lawless
et al., 2010]) compared to the early passage (Figure 3C). Further-
more, embryo fibroblasts from mice lacking Terc alone or in
combination with the mutations in the Werner and Bloom 30-50
DNA helicases (Du et al., 2004) expressed greater Ifnb levels
than wild-type cells (Figure 3D). In addition, tissues from Terc
knockout mice bred to shorten the telomeres and produce
persistent DDR (Choudhury et al., 2007; Du et al., 2004; Ju
Figure 1. Induction of Double-Strand
Breaks Leads to Production of Functional
IFN-b Protein
(A) IFN-b protein was detected in FLAG-tagged
TRF1-FokI (wild-type or nuclease-inactive D450A
mutant)-transfected mouse embryo fibroblasts.
Immunofluorescence using indicated antibodies is
shown. Magnification bar for all panels, 10 mm.
(B) Levels of TRF-FokI proteins detected by
immunoblotting (upper panel) and quantification of
percentage of cells single or double positive (red
bars) for FLAG and IFN-b proteins in 22–25 fields
randomly chosen from three independent experi-
ments performed as described in (A) (lower
panel). Here and thereafter, data are shown as
average ±SEM; *p < 0.05; **p < 0.01; ***p < 0.001.
(C) Expression of Irf7 promoter-driven IRF7-
mCherry fusion protein in TRF1-FokI-transfected
NIH 3T3 cells treated as indicated with RNAi
(control or against Ifnb) or antibodies (control IgG
or neutralizing antibody against mouse IFN-b,
10 mg/ml for 72 hr after transfection).
(D) Immunofluorescent detection of IFN-b-positive
cells after induction of DSB with 4-OHT (2.5 mM)
and Shield (1 mM) compound for indicated times in
the U2OS-DSB reporter cells (U2OSr) cells.
(E) Quantification of data shown in (D) in nine to 11
fields randomly chosen from three independent
experiments.
(F) Immunoblot analysis of lysates from the U2OSr
cells transfected with indicated RNAi and treated
or not with 4-OHT (2.5 mM) and Shield (1 mM)
compound for 6 hr.et al., 2007) displayed substantially greater mRNA levels of Ifnb
(but not Ifna4, (Figure 3E) and diverse IFN-stimulated genes (Fig-
ure 3F). Collectively, these results suggest that persistent DDR
induces IFN-b and a functional IFN response in vitro and in vivo.
DDR-Induced IFN-b Promotes Cell Senescence
Cells exposed to chronic DDR secrete inflammatory cytokines
that can permanently halt their division (Coppe´ et al., 2010;
Tchkonia et al., 2013). Therefore, we sought to determine
whether DDR-induced IFN-b has a role in promoting growth ar-
rest and senescence. Treatment of fibroblasts from Werner
andHutchinson-Gilford progeria syndrome patients with neutral-Cell Reports 11, 785izing antibody against human IFN-b stim-
ulated entrance of cells into S and G2M
cell-cycle phases (Figure 4A). Further-
more, an elevated level of senescence-
associated b-galactosidase (SA-bGal)-
positive cells (compared to normal
IMR90 cells, Figure S2A) observed in cul-
tures of patients’ cells was also markedly
reduced by anti-IFN-b antibody (Fig-
ure 4B). Similarly, this antibody treatment
or knockdown of IFNAR1 decreased the
number of SA-bGal-positive cells in late-
passage cultures of MRC5 fibroblasts
(Figure S2B). Expression of other senes-cence markers such as macroH2A, heterochromatin protein-
1b, p21CIP1/WAF1, and p16INK4A was also attenuated by neutral-
izing IFN-b in human cells (Figure 4C).
Consistent with our previous report (Du et al., 2004), greater
numbers of SA-bGal-positive cells were observed in Terc/
and Werner-Bloom-Terc/ embryo fibroblasts compared to
cells fromwild-typemice (Figure S2C). Anti-IFN-b antibody treat-
ment decreased senescence as judged by SA-bGal staining (Fig-
ure 4D) and expression of other senescencemarkers (Figure 4E).
Furthermore cells from Ifnar1/ mice cultured at normoxic
conditions to stimulate oxidative stress-induced senescence ex-
hibited significantly fewer senescent cells compared towild-type–797, May 5, 2015 ª2015 The Authors 787
Figure 2. Effect of DSB Induction on IRF3
Localization
(A) Immunofluorescent detection of IFN-b-positive
cells before (‘‘off’’) or after (‘‘on’’) induction of DSB
with 4-OHT (2.5 mM) and Shield (1 mM) compound
for 6 hr in the U2OSr cells that were prior either
transfected with indicated siRNA oligos for 66 hr or
pretreated with ATM inhibitor (Ku55933, 10 mM for
1 hr). Magnification bar for all panels, 10 mm.
(B) Recruitment of IRF3 to the DNA-damage foci
after inducing DSB with 4-OHT/Shield compounds
for indicated times detected by immunofluores-
cence in the U2OSr cells.
(C) Quantification of cells containing IRF3-positive
foci in the nucleus in eight to ten fields randomly
chosen from three independent experiments per-
formed as described in (B) and (D).
(D) Recruitment of IRF3 to the DNA-damage foci in
the U2OSr cells pre-treated with vehicle or ATM
inhibitor (Ku55933, 10 mM for 1 hr) or DNA-PK in-
hibitor (Nu7441, 4 mM for 1 hr) as indicated.
(E) IRF3 localization in U2OSr cells that received
indicated siRNA oligos 66 hr before inducing DSB
with 4-OHT (2.5 mM) and Shield (1 mM) compound
as in (D).cells (Figure S2D). Together these data suggest that DDR-
induced IFN-b mediates cell growth arrest and senescence.
IFN Contributes to Stem Cell Decline and Premature
Aging
Telomere shortening and persistent DDR in the inbred Terc/
mice lead to a decline in stem cell function in highly proliferative
tissues resulting in phenotypic manifestations reminiscent of
accelerated aging (Rudolph et al., 1999). Given that expression
of IFN-b and IFN-stimulated genes was also elevated in these788 Cell Reports 11, 785–797, May 5, 2015 ª2015 The Authorsmice (Figures 3E and 3F), we sought to
determine the role of IFN signaling in
these phenotypes. To this end, we
crossed G1 Terc/ mice with animals
lacking Ifnar1 and bred them to G4 (Fig-
ure S3A). Though parental Ifnar1-deficient
mice exhibited a trend for greater telo-
mere lengths, concurrent Terc ablation
dramatically shortened telomeres regard-
less of Ifnar1 status. Accordingly, a similar
extent of telomere shortening was found
in G4 Terc/; Ifnar1+/+ (‘‘SK’’) and G4
Terc/; Ifnar1/ (‘‘DK’’) mice (Fig-
ure S3B). Although, our qPCR technique
is more indicative of telomere abundance
than telomere length, it would be surpris-
ing for the Ifnar1 status to influence one
without the other (for example, stimulate
formation of extra-chromosomal telo-
mere repeat entities, which we were un-
able to observe; see Figure 6A below).
Thus, comparable telomere abundance
between SK and DK mice let us directlycompare the phenotypes in different tissues derived from these
animals.
Whereas guts from young SK mice hardly displayed gross ab-
normalities (Figure S3C), such changes became evident at
8 months of age. We found numerous distortions in the crypt
and villus architecture in SK animals (Figure 5A), including crypt
dropout (reduced crypt numbers in a given length of intestine),
villus blunting, and atrophy. In addition, prominent lymphocytic
infiltrates in the underlying stroma and thickening of the lamina
propria were indicative of inflammatory process. Concurrent
Figure 3. DSB Induces Expression of mRNA
of IFN-b
(A) Relative expression of Ifnb mRNA in response
to combined treatment with 4-OHT/Shield in
parental U2OS cells and U2OSr cells.
(B) Relative expression of Ifnb mRNA normalized
per GFP mRNA levels in NIH 3T3 cells co-trans-
fected with mouse genomic DNA (1 mg, sonicated
for indicated times) and GFP plasmid (100 ng) per
12-well plate well. Average data from three ex-
periments (each in triplicate) are shown. The right
panel depicts a representative ethidium bromide-
stained agarose gel demonstrating the length of
DNA fragments used for transfection. M (Markers):
GeneRuler 100bp Plus DNA Ladder.
(C) Relative levels of Ifnb mRNA in human fibro-
blasts (IMR90 levels taken as 1.0). Asterisks
indicates significant differences between MRC5
fibroblasts cultured for 66 passages over those
cultured for 37 passages (each passage being a
2-fold split) and between fibroblasts from patients
with Werner syndrome (WS, passage 23) or
Hutchinson-Gilford Progeria syndrome (HGPS,
passage 23) and normal IMR90 (passage 25).
(D) Relative levels of IfnbmRNA in fibroblasts from
wild-type (WT, taken as 1.0), late-generation
Terc/, or Werner-Bloom-Terc-deficient animals
(WBT).
(E) Relative levels of Ifnb and Ifna4 mRNA in gut,
spleen, and lymph nodes (LNs) tissues from late-
generation Terc/ mice compared to that in wild-
type mice (taken as 1.0).
(F) Relative levels of indicated IFN-stimulated
genes mRNA in spleen tissues from late-genera-
tion Terc/ mice compared to that in wild-type
mice (taken as 1.0).knockout of Ifnar1 in age-matched DK mice restored normal
crypt-and villus architecture, increased villus height and crypt
numbers, and reduced inflammation (Figure 5A). These results
suggest that IFN may play a role in the intestinal pathology
caused by Terc deficiency.
Even at a young age, we found evidence for increased IFN
signaling in the gut of Terc knockout animals. Consistent with
the observed ability of the DDR to induce IFN and IFN-stimu-
lated genes in vitro (Figures 1, 3, and 4), intestinal tissues
from 20- to 25-day-old SK mice displayed elevated IRF7 levels
(Figure 5B). Remarkably, a dramatic increase in senescence
evident from SA-bGal-positive staining (Figures 5C and 5D),
and decreased Ki67 staining (Figures 5E and 5F) was observed
in SK but not in DK animals. Furthermore, a significantly
reduced level of the cleaved caspase-3 was seen in DK mice
compared to SK mice (Figures 5G and 5H). Collectively, these
results suggest that proliferative arrest and increased apoptosis
observed in late-generation Terc-deficient mice depend on IFN
signaling.
We next sought to identify the effectors of IFN signaling that
mediate increased senescence and apoptosis. Prolonged treat-
ment of cells with recombinant IFN was shown to induce DNA
damage and p53 in vitro (Moiseeva et al., 2006; Takaoka
et al., 2003). While the levels of telomere dysfunction-inducedfoci (TIFs) that reflect accumulation of 53BP1 on uncapped telo-
meres (Suram et al., 2012; Takai et al., 2003) were comparable in
intestinal cells from SK and DKmice, TIFs were much less abun-
dant than the non-telomere associated 53BP1 foci (Figure 6A).
Furthermore, high non-telomere associated and overall levels
of 53BP foci in intestinal tissues from young or old SK animals
were decreased dramatically in the DK tissues (Figures 6A,
S4A, and S4B). These results suggest that endogenous IFN
acts to amplify DDR signaling downstream of telomere end un-
capping in Terc/ mice. In addition, the robust increase in p53
staining in the intestines of Terc-deficient mice was attenuated
by ablation of Ifnar1 (Figure 6B). These in vivo results were
also seen in tissue from 8-month-old mice (Figure S4C) and
are consistent with the earlier observation that neutralization of
endogenous IFN-b produced by DDR-exposed cells markedly
reduced p53 levels (Figures 4C and 4E). Finally, Ifnar1 ablation
also mitigated the Terc-deficiency-induced increase in the
cyclin-dependent kinase inhibitors p16INK4a (Cdkn2a) and
p21CIP1/WAF1 (Cdkna1) and apoptosis regulators Puma (Bbc3)
and Bax (Figures 6C and 6D). These results are consistent
with an important in vivo role of endogenous IFN in amplification
of DDR signaling and activation of molecular regulators of
senescence and apoptosis prompted by the telomere
shortening.Cell Reports 11, 785–797, May 5, 2015 ª2015 The Authors 789
Figure 4. Role of IFN-b in DNA-Damage-Induced Senescence of Mouse and Human Fibroblasts
(A) Cell-cycle distribution of fibroblasts from patients with Hutchinson Gilford Progeria (HGPS) andWerner (WS) syndrome cultured in the presence of neutralizing
antibody against human IFN-b or control antibody (IgG, both at 10 mg/ml for 48 hr).
(B) Expression of SA-bGal by HGPS and WS human fibroblasts cultured in the presence of neutralizing antibody against human IFN-b or control antibody (IgG,
both at 10 mg/ml for 3–4 days). Magnification bar, 100 mm. Quantitated data reflect at least 200 total cells counted in three independent experiments.
(C) Expression of protein markers of senescence (mH2A, Hp1b, p21, p16, p53) in MRC5 fibroblasts (passage 37 or 66) and in WS fibroblasts was analyzed by
immunoblotting using the indicated antibodies. IRF7 protein levels serve as an IFN-induced gene product control. Levels of b-actin were used as a loading
control.
(D) Expression of SA-bGal by Terc/ andWBT fibroblasts cultured in the presence of neutralizing antibody against murine IFN-b or control antibody (IgG, both at
10 mg/ml for 10 days). Magnification bar, 100 mm. Quantitated data reflect at least 200 total cells counted in three independent experiments.
(E) Expression of protein markers of senescence (Hp1b, p21, p16, p53, and p19ARF) in wild-type, Terc/ and WBT fibroblasts was analyzed by immunoblotting
using the indicated antibodies. IRF7 protein levels serve as an IFN-induced gene product control. Levels of b-actin were used as a loading control.Because inability to maintain telomere length leads to the fail-
ure of stem cells, we investigated the expression of the Wnt
pathway-induced genes known to play an important role in intes-
tinal stem cell self-renewal (Formeister et al., 2009). Intriguingly,
expression of Lgr5 and Sox9 was noticeably increased in the
Ifnar1/mice (Figure 6D) suggesting a role for IFN in the regula-
tion of theseWnt targets. Importantly, knockout of Ifnar1 relieved
the inhibition of Lgr5 and Sox9 expression observed in Terc/
intestines (Figure 6D). These data suggest that DDR-induced790 Cell Reports 11, 785–797, May 5, 2015 ª2015 The AuthorsIFN may inhibit additional pathways that are essential for the
function of intestinal stem cells.
We further compared the hematopoietic stem cell compart-
ments in DK and SK mice. Consistent with the ability of IFN to
stimulate LSK proliferation (Essers et al., 2009), relatively low
number of hematopoietic Lineage Sca1+ c-Kit+ stem/progeni-
tor cells (LSK) was seen in Ifnar1-deficient bone marrow (Fig-
ure 7A). SK mice had low number of LSK cells and long-term
self-renewing LSK CD150+CD48 stem cells (Figures 7A and
Figure 5. IFN-Dependent Proliferative Failure, Senescence, and Apoptosis in the Gut Tissues from Terc-Deficient Mice Is Rescued by Ifnar1
Ablation
(A) H&E staining of the intestinal tissues from 8-month-old male mice of indicated genotypes. Magnification bar here and thereafter, 100 mm.
(B) Immunofluorescent analysis of IRF7 expression in the intestinal tissues of 22- to 25-day-old mice of indicated genotypes. Right panel depicts the number of
IRF7-positive cells per field in the small intestines of three mice (at least ten random fields observed for each).
(C) Analysis of SA-bgal-positive cells in the intestinal tissues (counterstained with Nuclear Fast Red) of 22- to 25-day-old mice of indicated genotypes.
(D) Quantitation of the number of SA-bGal-positive cells per basal crypt in the small intestines of three mice (30–100 crypts were analyzed for each).
(E) Immunofluorescent analysis of Ki67 levels in the intestinal tissues of 22- to 25-day-old mice of indicated genotypes.
(F) Quantitation of the number of Ki67-positive cells per basal crypt in the small intestines of three mice (30–100 crypts were analyzed for each).
(G) Immunofluorescent analysis of cleaved caspase-3 levels in the intestinal tissues of 22- to 25-day-old mice of indicated genotypes.
(H) Quantitation of the number of cleaved caspase-3 -positive cells per field in the small intestines (at least ten random fields observed for each of three mice).
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Figure 6. IFN Signaling Amplifies DDR and Ensuing Expression of Senescence Mediators in the Intestines from Terc-Deficient Mice
(A) Immunofluorescent analysis of telomere dysfunction-induced foci (arrows) using PNA telomere probe and anti-53BP1 antibodies. Two representative crypts
are shown for each Ifnar1 background (top for SK, and bottom for DK). The number of PNA-associated, non-PNA-associated and total 53BP1 foci per intestinal
crypt was scored in at least 50 crypts. Magnification bar, 20 mm.
(B) Immunofluorescent analysis of p53 expression in the intestinal tissues from 22- to 25-day-oldmice of indicated genotypes. Right panel depicts the percentage
of p53-positive crypts in the small intestines (30–100 crypts were analyzed for each of three mice). Magnification bar, 50 mm.
(C) Immunofluorescent analysis of p16INK4A expression in the intestinal tissues from 22- to 25-day-old mice of indicated genotypes. Right panel depicts the
number of p16INK4A-positive cells per field (at least ten random fields observed for each of three mice). Magnification bar, 100 mm.
(D) Relative mRNA levels of indicated genes in the indicated mouse intestines assessed by qPCR (levels in wild-type mice taken as 1.0). Expression of Ifit3m
mRNA was used as a control for a bona fide IFN-stimulated gene.7B), and SK bone marrow cells displayed a limited ability to form
colonies in vitro (Figure 7C). Remarkably, both counts were
increased by knockout of Ifnar1 in the DK mice. These results
point to the contribution of DDR-induced IFN to the depletion
of hematopoietic stem cells and early progenitors in Terc/-
deficient animals (Figures 7A and 7B) and suggest that at least
a part of this contribution (noticed in the in vitro assay) is cell
autonomous and is not influenced by status of IFN signaling in
the stem cell niche (Figure 7C). Furthermore, consistent with
increased myeloid proliferation and lymphoid lineage failure in
these mice (Ju et al., 2007), we found a greater number of
myeloid cells and fewer lymphocytes in their spleens. Both phe-
notypes were reversed in DKmice (Figure S5A). In all, these data
are suggestive of an important role for DDR-induced IFN in
renewal/proliferation of hematopoietic stem cell and progenitors
and their ability to contribute to a specific lineage.
We next sought to determine the role of IFN signaling in the
germinal stemcell failureand fertility/fecundityproblems reported792 Cell Reports 11, 785–797, May 5, 2015 ª2015 The Authorsin later generations of Terc-deficient mice (Lee et al., 1998; Ru-
dolph et al., 1999). Depletion of germcells and atrophy of seminif-
erous tubulesobserved in testes fromTerc/micewerenot seen
in age-matchedDKmice (Figure 7D). Furthermore, Ifnar1 ablation
efficiently rescued a reduction in number of litters (Figure 7E) and
litter size (Figure 7F), indicating that germinal stem cell failure trig-
gered by persistent DDR signaling is mediated by IFN.
Terc-deficient mice exhibit other gross signs of premature ag-
ing, including frequent appearance of gray hair and overall body-
size reduction (Lee et al., 1998; Rudolph et al., 1999). We have
also observed these phenotypes in the SK animals. Most
remarkably, knockout of Ifnar1 in these mice decreased the
amount of gray hair and robustly increased animal body weight
and size (Figures 7G and S5B). Finally, abrogation of IFN
signaling substantially increased the longevity of Terc-deficient
animals (Figure 7H). These results suggest that IFN signaling
plays a central role in DDR-stimulated development of progeroid
phenotypes arising from critically shortened telomeres.
Figure 7. DDR-Induced IFN Signals Play a Key Role in Failure of Stem and Germ Cells and Development of Phenotypes Associated with
Premature Aging in the Terc-Deficient Mice
(A) Number of hematopoietic precursor cells (LSK) in the bone marrow from 22- to 25-day-old mice of indicated genotypes calculated from at least four individual
animals.
(B) Number of hematopoietic stem cells (LSKCD150+CD48) in the bonemarrow from 22- to 25-day-oldmice of indicated genotypes calculated from at least four
individual animals.
(C) Colony forming efficiency of bone marrow cells from age-matched mice of indicated genotype.
(D) H&E staining of the testis tissues from 22- to 25-day-old male mice of indicated genotypes.
(E) Number of litters per a mating pair (per first 4 months of mating) in mice of indicated genotypes (n = 8 pairs for each genotype).
(F) Number of pups per litter in mice of indicated genotypes (n = 7 for litters per each genotype).
(G) Characteristic physical appearance and average body weight of 22- to 25-day-old mice of indicated genotypes (n = 10).
(H) Kaplan-Meier analysis of survival of G4 mice of indicated genotypes.DISCUSSION
Here, we demonstrate that DNA damage in mammalian cells can
signal cell-autonomously to induce endogenous IFN-b in anATM-IKKa/IKKb-IRF3-dependent manner (Figures 1, 2, and 3).
Expression of endogenous IFN-b and IFN-stimulated genes is
increased in vitro and in vivo in cells and tissues characterized
by persistent DNA damage (Figure 3). This IFN-b furtherCell Reports 11, 785–797, May 5, 2015 ª2015 The Authors 793
activates the p53-p21 axis and increases the levels of p16INK4
concurrent with robustly promoting cell senescence in vitro (Fig-
ure 4). Moreover, persistent DDR signaling and the resultant
pathogenic sequelae observed in Terc knockout mice are allevi-
ated by concomitant deficiency in Ifnar1 signaling, which is
responsible for induction of mediators of senescence and
apoptosis (Figures 5 and 6), failure of stem cells, and ensuing
premature aging and shortened lifespan (Figure 7). Together
these results demonstrate that DDR-induced IFN signaling rep-
resents a key mechanism linking accumulation of DNA damage
with cell senescence, stem cells failure, tissue aging, and prema-
ture death.
Current results including correlation between number of DSBs
in foreign DNA and its ability to induce IFN-b (Figure 3B) demon-
strate that DNA damage per se leads to cell-autonomous pro-
duction of IFN-b. It is plausible that this phenomenon evolved
to respond to DSB signals elicited by un-integrated viruses to
limit virus-induced genomic DNA alterations (Katze et al., 2002)
thereby guarding the genome integrity. The nature of a sensor
for DSB that triggers signaling toward IFN production may plau-
sibly differ from the known sensors/mediators of responses to
un-damaged cytoplasmic dsDNA such as STING or AIMII
(Barber, 2011a). The details of signaling leading to IRF3 activa-
tion via IKKa and IKKb (previously shown to be activated by
DNA damage in an ATM-dependent manner [McCool and Miya-
moto, 2012]) remain to be elucidated. Roles of additional DNA-
damage-inducible regulators of Ifnb expression (e.g., NF-kB/
AP1/ATF2 [Bhoumik et al., 2005; Herrlich et al., 1994; Lau
et al., 2012]), and additional pathogen recognition receptor-
mediated mechanisms are currently being investigated.
It has been suggested that the primary function of cell senes-
cence is anti-viral defense (Reddel, 2010). Consistent with this
hypothesis, our current data indicate that DDR-induced endog-
enous IFN-b, a major anti-viral cytokine, plays an important role
in development of senescence (Figures 4 and 5). The mecha-
nisms by which DDR-induced IFN-b contributes to cell senes-
cence are likely to be complex. Current data suggest that
IFN-b-stimulated activation of IFNAR1 and downstream IFN-
stimulated genes (Figures 5 and S2) that act in concert to
promote the DNA-damage-induced senescence. Underlying
IFN-stimulated mechanisms may include amplification of the
DDR (Figure 6A) and activation of the p53 pathway, which func-
tions as a central regulator of senescence (Ventura et al., 2007;
Xue et al., 2007). Indeed, IFN mediates DDR-induced upregula-
tion of p53, p21CIP1/WAF1, and p16INK4A; Figure 6), thereby iden-
tifying these proteins as important effectors of IFN signaling that
links DNA damage and senescence. Additional roles of other
IFN-inducible genes (e.g., Ifi16/Aim2 [Duan et al., 2011]) that
can contribute to development of cell senescence should not
be ruled out.
Genetic ablation of Ifnar1 abolishes pathological abnormalities
in vivo associated with premature aging and death in animals
where DDR persists due to telomere shortening (Figure 7). While
our data demonstrate comparable levels of telomere dysfunc-
tion-induced foci in SK and DK cells, it is still plausible that IFN
may have an auxiliary role in regulating telomere end capping/
de-capping. However, the dramatic increase of non-telomere
associated DNA damage in SK but not DK cells (Figure 6A) sug-794 Cell Reports 11, 785–797, May 5, 2015 ª2015 The Authorsgest that IFN amplifies DNA damage downstream of telomere
deficiency. Regardless of the mechanisms contributing to the
IFN-dependent pathology, the attenuation of Terc-deficient phe-
notypes by ablating Ifnar1 is striking. Given that similar rescue
was seen in p53 or p21CIP1/WAF1 knockout mice (Chin et al.,
1999; Choudhury et al., 2007) and the role of IFN in expression
of thesemediators (Figure 6), it is likely that the p53-p21 pathway
functions as an effector of DDR-induced IFN signaling respon-
sible for cellular senescence, failure of stem cell function, and
phenotypes associated with premature aging. Additional IFN-
dependent activation of p16INK4A and effect on some of Wnt
pathway target genes (Figure 6) may also contribute to these
processes.
As DNA damage accumulates with age and correlates with an
age-related decline in stem cell function (Campisi and d’Adda di
Fagagna, 2007), it is likely that IFN-mediated suppression of self-
renewal capacity, exhaustive proliferation, and ensuing senes-
cence of stem cells may play an important role in aging of rapidly
renewable tissues such as bone marrow and intestine. Our cur-
rent data together with the demonstrated ability of IFN to stimu-
lated proliferation of hematopoietic stem cells leading to their
eventual depletion (Essers et al., 2009; Sato et al., 2009) suggest
that DDR-induced IFN may act through this mechanism. The
cell-autonomous role of IFN signaling in declining function of
these cells is further supported by our in vitro data (Figure 7C).
In addition, IFN might also act indirectly via altering the stem
cell niche (demonstrated in Terc knockouts [Song et al., 2010])
and exacerbating inflammation in peripheral tissues (Bhatta-
charya et al., 2014).
Importantly, our in vitro and animal data presented here are
consistent with clinical observations of increased cell senes-
cence found in patients with hepatitis C undergoing treatment
with IFN (O’Bryan et al., 2011). Furthermore, elevated IFN activ-
ities found in aging human and mouse brains were implicated in
aging-related cognitive decline (Baruch et al., 2014). Further
investigation of the role of IFN in accelerated and normal aging
is warranted.
EXPERIMENTAL PROCEDURES
Animals
All experiments using animals were carried out under the protocols 803995 and
804470 approved by the IACUC of The University of Pennsylvania. All mice
were of C57Bl/6J background and had water ad libitum and were fed regular
chow. Ifnar1/mice (gift of Dr. Dong-Er Zhang, UCSD)were crossedwith telo-
merase knockoutmice (G1Terc/ [Blasco et al., 1997; Rudolph et al., 1999]) to
generate Terc+/, Ifnar1+/mice. These mice were backcrossed with Ifnar1/
or Ifnar1+/+mice and then subjected to cousin mating through successive gen-
erations to produce G4 Terc/, Ifnar1/ (DK) or G4 Terc/, Ifnar1+/+ (SK)
mice (Figure S3). Telomere length in genomic DNA from age-matched animals
was assessed by qPCR as reported elsewhere (Choudhury et al., 2007; Du
et al., 2004; Ju et al., 2007). cDNAwas used for qPCR (with primers listed in Ta-
ble S1) that was carried out using Applied Biosystems 7500 Fast Real-Time
PCR system.
Cells
HeLa, 293T, IMR 90, NIH 3T3 cells that stably express IRF7-mCherry fusion
protein under control of Irf7 promoter (Rand et al., 2012), U2OS and U2OS re-
porter cells (U2OSr, described in details in Tang et al., 2013), primary mouse
embryo fibroblasts from late-generation Terc/ mice (C57Bl/6J background)
and Wrn/ Blmm3/m3 Terc/ mice (mixed background: 50% C57BL/6J,
37.5% 129Svj, 12.5% BALB/c; described in Du et al., 2004), and MRC5 cells
were cultured in DMEM plus 15% fetal bovine serum (FBS). Human diploid
fibroblast (HDF) cells from patients with Hutchinson-Gilford progeria syn-
drome (HGPS, cell line AG0989B) and Werner syndrome (WS, cell line
AG05229B) were purchased from Coriell Institute for Medical Research.
MRC5, HGPS, and WS cells were cultured in a Billups-Rothenberg modular
incubator chambers at 3% O2 until they were transferred to 20% O2 culture
condition to induce senescence. Transient transfections of cells with siRNA
oligos (listed in Table S2) used Lipofectamine RNAiMAX Transfection Reagent
(Invitrogen).
qPCR, Immunotechniques, and Other Analyses
Immunoblotting and FACS analyses procedures were described previously
(Bhattacharya et al., 2014; Li et al., 2004; Zheng et al., 2011). Analyses of
dysfunctional telomere-induced foci were carried out in the intestines from
Terc-deficient mice differing in the Ifnar1 background. Tissue sections were
hybridized with a Cy3-labeled PNA telomere repeat probe ([CCCTAA]3)and
Alexa-Fluor-488-labeled anti-53BP1 antibodies (Novus, NB100-304) as
described in Suram et al. (2012). Total 53BP1-positive foci per basal crypt
were counted in 40 random fields. The number of positive cells per crypt
(SA-bGal, Ki67) or per field (IRF7, cleaved caspase-3, and p16INK4a) was
counted in 20 random low-power fields. Each analysis was repeated in three
mice per genotype group. Summary data are shown as mean ± SEM.
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